在型肝炎病毒治疗后肝酶升高的患病率和危险因素
Helen L Zhang1, Hayley Nemeth2, E Wilbur Woodhouse3
1Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
Journal of viral hepatitis
|October 3, 2024
概括
在C型肝炎病毒 (HCV) 治疗后,较高的治疗前ALT和肝硬化增加肝酶升高 (LEE) 风险. 女人的性是保护性的. 这有助于识别需要更密切监测后持续病毒反应 (SVR) 的患者.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 临床医学 临床医学
背景情况:
- 慢性型肝炎病毒 (HCV) 感染是一个全球性的健康问题.
- 直接作用抗病毒药物 (DAA) 疗法实现了高持续病毒学反应 (SVR) 率.
- 一小部分患者在SVR后经历肝酶升高 (LEE),风险因素不明.
研究的目的:
- 在获得持续病毒学反应 (SVR) 后,在患有型肝炎病毒 (HCV) 感染的患者中确定肝酶升高 (LEE) 的风险因素.
- 描述SVR后肝损伤的预测因素.
主要方法:
- 对1356名感染HCV的成年患者进行了回顾性队列研究,这些患者接受了DAA治疗.
- 使用了多变量逻辑回归和通用线性混合效应模型.
- 分析的重点是预处理因素和与SVR后LEE的关联.
主要成果:
- 41.0%的患者在SVR后经历了LEE.
- 治疗前阿氨酸转移酶 (ALT) 和治疗前肝硬化水平较高显著与LEE的几率增加有关.
- 男性的性别与LEE的几率较低有关;在HIV和LEE之间没有发现显著的关联.
结论:
- 治疗前的ALT水平,肝硬化和性别是HCV SVR后LEE的重要预测因素.
- 这些发现有助于识别患有SVR后肝损伤风险较高的患者.
- 针对处于风险的人群,可以实施有针对性的监测.
相关概念视频
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


